Ionis Pharmaceuticals, Inc. (0JDI.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 12.72B |
| Enterprise Value | 15.17B |
| P/E Ratio | -38.14 |
| PEG Ratio | 7.12 |
| Price/Sales Ratio | 11.86 |
| Price/Book Ratio | 25.46 |
| Enterprise/Revenue | 13.62 |
| Enterprise/EBITDA | 3.14 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.31 |
| Operating Margin | -0.33 |
| Return On Assets | -0.09 |
| Return On Equity | -0.59 |
| Revenue | 944M |
| Revenue/Share | 6.42 |
| Gross Profit | 928M |
| EBITDA | -358.99M |
| Net Income | -381M |
| Diluted EPS | -2.38 |
| Total Cash | 1.98B |
| Total Cash/Share | 11.64 |
| Total Debt | 2.61B |
| Total Debt/Equity | 4.15 |
| Current Ratio | 4.1 |
| Book Value Per Share | 2.98 |
| 52-Week Change | 103.28 |
| 52-Week High | 76.6 |
| 52-Week Low | 33.21 |
| Moving Average 50 Days | 48.72 |
| Moving Average 200 Days | 44.34 |
| Average Volume | 351 |
| Shares Outstanding | 161.56M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |